Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol.
about
Binding of [3H]haloperidol to dopamine D2 receptors in the rat striatumDopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.[3H]Metergoline: a new ligand of serotonin receptors in the rat brain.Fifty years chlorpromazine: a historical perspective.Mind molecules.Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sitesChlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations.Androgen-induced sexual dimorphism in high affinity dopamine binding in the brain transcends the hypothalamic-limbic region.DNA methylation modifies the association between obesity and survival after breast cancer diagnosis.Dietary trace amine-dependent vasoconstriction in porcine coronary artery.Dopamine in substantia nigra and cortex after gamma-butyrolactone treatment.Neurotransmitter receptor binding: regional distribution in human brain.Characterization of solubilized dopamine receptors from dog striatum.Neurochemical parameters in the hyperresponsive phase after a single dose of neuroleptics to mice.Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain.The opiate receptor and opoid peptides.Regulation of cyclic GMP in cerebellum by a striatal dopaminergic mechanism.Multiple neurotransmitter receptors.The history of the psychopharmacology of schizophrenia.Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas.Multiple dopamine binding sites: subcellular localization and biochemical characterization.Solubilisation of high-affinity dopamine receptors.A comparison of the binding of sigma opioids and phencyclidine, and the interaction with antipsychotic drugs in rat brain membranes.Hypotensive and sedative properties of alpha-adrenoceptor agonists: relation to pre- and post-synaptic stimulation [proceedings]Rem sleep deprivation in an experimental model of Parkinson's disease.Regional distribution of the synaptic membrane proteins: synaptin, D1, D2 and D3.Protective effects of N-acetyl-L-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine.Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys.Nicotine normalizes increased prefrontal cortical dopamine D1 receptor binding and decreased working memory performance produced by repeated pretreatment with MK-801: a PET study in conscious monkeys.Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum.Direct evidence for presynaptic and postsynaptic dopamine receptors in brain.Receptor basis for dopaminergic supersensitivity in Parkinson's disease.A sensitive enzymatic-radioisotopic assay for apomorphine.Serotonergic component of neuroleptic receptors.Possible relationship between glial cells, dopamine and the effects of antipsychotic drugs.Effects of dopaminergic drugs on cerebellar prostaglandin concentrations.Dopamine receptors in the retina may all be linked to adenylate cyclase.The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drugThe dopamine connection
P2860
Q28327835-F4E97471-8041-4D03-A610-192035FD06C4Q34192438-A259774E-C460-42F0-B039-FE5C62B1B2ECQ34288053-046A431A-1C9E-4557-852F-B71E7DA8F0B2Q34965972-A0AA4525-8297-40DA-BE07-B16EB66D3DB1Q35065098-F4F9A6BC-6863-4D0B-B8E6-AFB68BB4D2B9Q35368949-53BAF5BD-C48E-489E-AA0E-E70E839445B0Q36097059-99D38D57-AEF7-4473-9485-7B8750B5A6D2Q36127819-B9E23985-FAC6-47DE-8C0A-E5CEADD3D83CQ36961072-98B7FC0B-361F-4F40-BEBD-F36AD715FF31Q36964909-1A7ACC27-EF69-478A-81AC-FDC33B4B9CCAQ39104139-E34C3385-DE77-4EDB-BC22-9F3BC5885A76Q39132022-85F5CC51-FEA7-48CB-9D5E-64DCB75BE937Q39256989-02739497-5396-4B1C-961D-6A0139198F45Q39270059-62696A92-A355-417E-812E-B31E098BEA59Q39656985-F7F78FC1-2B3F-4DB1-86AA-073FBE0A5941Q40041218-045C139E-73E6-400B-B2F2-0A575692DD8FQ40042642-A06EE186-B665-48D4-8F02-A332EF836156Q40123055-5F0D6EA2-EDD3-421B-88A7-01852E622C11Q41380354-8DE31A13-4FFF-4781-BA13-1EC290571827Q41461238-89F42F96-1FC2-475A-8406-13804BD26EA1Q41504392-568F90EE-0E72-4E08-9370-A5E260BD8373Q41644779-919CB32F-8B65-46D6-BE66-610B82D4B466Q42266625-AF4EFB26-3669-4B13-B6E5-BF7F7A0FAD5DQ42631792-3749A2F9-CC5B-45EA-830A-E1A4C0D950F7Q42657228-D896195E-4782-4558-B205-C6162599C43CQ44004628-06BF03D0-5CF4-4CBF-983D-B15C6ABF3BC7Q44938364-A8F99FA3-0F38-48CF-8BDF-178AB71900F1Q46446316-2C1BD349-BE89-43B4-8605-80260C6854E8Q46459290-C27131E8-08AD-4D4D-ABCF-15E105086ABCQ46677579-6687167D-9BF2-4D29-BC79-612E72E20429Q46857388-872AFD6E-0AAE-4482-A291-6807D3886FDDQ48174113-782974B7-FBB4-4251-902E-71C254285A38Q48190564-482B23FC-38C6-4770-AFF8-49866BF22497Q48192092-74721C2C-CBA1-4B9E-9BEB-B857AE0178B3Q48203921-B2A2DD71-42DF-4A04-971A-250E348767CCQ48299825-0D1C6BE1-53C5-49C3-AEAB-063B16246FDAQ48732978-400E3EB7-2818-4A4F-93F7-21D7E59410E1Q53969206-05A5D0CE-6F93-42EF-842A-E44C92329E3EQ56985749-2CD145B1-CCD6-4880-8A1C-FB3D41204C9AQ59010930-175106C5-A15B-4AD0-98AB-997C5900D0F9
P2860
Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh-hant
name
Dopamine receptor binding: dif ...... H-dopamine and 3H-haloperidol.
@en
Dopamine receptor binding: dif ...... H-dopamine and 3H-haloperidol.
@nl
type
label
Dopamine receptor binding: dif ...... H-dopamine and 3H-haloperidol.
@en
Dopamine receptor binding: dif ...... H-dopamine and 3H-haloperidol.
@nl
prefLabel
Dopamine receptor binding: dif ...... H-dopamine and 3H-haloperidol.
@en
Dopamine receptor binding: dif ...... H-dopamine and 3H-haloperidol.
@nl
P2093
P1433
P1476
Dopamine receptor binding: dif ...... H-dopamine and 3H-haloperidol.
@en
P2093
P304
P356
10.1016/0024-3205(75)90454-3
P407
P577
1975-09-01T00:00:00Z